trending Market Intelligence /marketintelligence/en/news-insights/trending/dlP_qjAtui3VbWwRhlFfoQ2 content esgSubNav
In This List

NutriBiotech Q3 profit climbs YOY


Street Talk | Episode 94: Recessionary fears in '22 overblown, Fed could overtighten


Optimism abounds in Indian online video industry


2022 broadband forecast shifts to market share battle with intense competition


Expand Your Perspective: Innovation

NutriBiotech Q3 profit climbs YOY

Nutribiotech. Co.Ltd. said its third-quarter normalized net income was 287.75 South Korean won per share, a gain from 71.83 won per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 2.37 billion won, a gain from 593.7 million won in the year-earlier period.

The normalized profit margin rose to 11.3% from 5.1% in the year-earlier period.

Total revenue grew 80.4% on an annual basis to 20.88 billion won from 11.58 billion won, and total operating expenses rose 65.4% from the prior-year period to 17.08 billion won from 10.33 billion won.

Reported net income increased on an annual basis to 2.99 billion won, or 364.00 won per share, from 809.9 million won, or 98.00 won per share.

As of Nov. 9, US$1 was equivalent to 1,161.10 South Korean won.